Computational prediction of HLA class II restricted T cell epitopes has great significance in many immunological studies including vaccine discovery. With the development of novel bioinformatics approaches, prediction of HLA class II binding has improved significantly but a strategy to predict the most dominant HLA class II epitopes has not been defined. Using different sets of peptides from various allergen and bacterial antigens and HLA class II binding prediction tools from the IEDB, we have designed a strategy to predict the top epitopes from any antigen. We found that the top 21% of 15-mer peptides overlapping by 10 residues (based on the predicted binding to seven DRB1 and DRB3/4/5 alleles) capture 50% of the immune response. This corresponded to an IEDB consensus percentile rank of 19.82 which could be used as a universal prediction threshold.
INTRODUCTION
Prediction and identification of HLA class II restricted T cell epitopes is a task of significance for several applications, including studying the immune response against pathogens or allergens, or deimmunization of protein-based drugs. Class II molecules are alpha/beta heterodimers encoded by four different loci in humans: DRB1/DRA, DRB1/DRB3/4/5, DPA/DPB and DQA/DQB. HLA class II polymorphism presents a challenge for epitope identification [9] . However, the problem is simplified by focusing on the alleles most frequently expressed in the general population, which account for an overwhelming majority of the expressed genes [4] . Furthermore, extensive similarities exist within the peptides bound by different allelic variants [3] . Accordingly, peptides capable of binding multiple HLA class II molecules (i.e., promiscuous peptides) often account for a large fraction of antigen specific T cell responses [6, 8] . While computational predictions of HLA class II binding capacity have improved as novel bioinformatic approaches have been implemented [5, 8, 12] , a strategy to predict the most dominant HLA class II epitopes has not been defined.
MATERIALS AND METHODS

Immunogenicity studies
Sets of overlapping 15 or 16mer peptides spanning various allergen and bacterial antigens were screened for immune reactivity as previously described [1, 6, 7] (Supplemental Table  1 ). Antigen specific cytokine production induced in donor PBMC was measured in dual ELISPOT assays. Responses to timothy grass, cockroach and house dust mite peptides were measured following in vitro stimulation with respective allergen extracts, and responses to Bordetella pertussis antigens following stimulation with corresponding peptide pools. Responses to mycobacterial antigens were analyzed ex vivo. Peptide specific responses were expressed as spot-forming cells (SFCs)/10 6 peripheral-blood mononuclear cells (PBMCs). Donors were HLA typed at each class II locus to four-digit resolution by SSP or deep sequencing methods [11] .
Prediction of binding affinity
Peptide affinity for HLA class II alleles was predicted using the MHC II binding prediction tool available at the IEDB (www.iedb.org) [10, 11] . Allele-specific consensus percentile ranks of all algorithms queried by the IEDB tool were utilized [12] . A percentile rank is generated by comparing the selected peptide's predicted binding affinity against that of a large set of similarly sized peptides randomly selected from the SWISS-PROT database. Percentile rank provides a uniform scale allowing comparisons across different predictors. A lower percentile rank indicates higher affinity. In the case of consensus method, median of the percentile ranks of the three methods involved is considered as the IEDB consensus percentile rank.
Correction for epitope redundancy
Responses against two consecutive peptides are often due to the same minimal epitope. To avoid counting the same epitope twice, two consecutive responses with magnitudes within 2.5-fold of each other were merged into a single antigenic region, and the higher SFC value utilized. The region is considered successfully Permission to make digital or hard copies of all or part of this work for personal or classroom use is granted without fee provided that copies are not made or distributed for profit or commercial advantage and that copies bear this notice and the full citation on the first page. Copyrights for components of this work owned by others than the author(s) must be honored. Abstracting with credit is permitted. To copy otherwise, or republish, to post on servers or to redistribute to lists, requires prior specific permission and/or a fee. Request permissions from Permissions@acm.org. predicted if either of the two peptides is predicted, and "credit" for prediction is given only once.
RESULTS AND DISCUSSION
Definition of alternative prediction strategies for HLA class II epitopes
Predicted binding of peptides in the data sets (Supplemental Table  1 ) for a previously described set of 26 HLA class II alleles that are most frequent in the general worldwide population [3] (Supplemental Table 2 ), was determined as described above. To evaluate the efficacy of various approaches to identify the most dominant epitope responses, employing these predictions, the percentage (fraction) of peptides in each data set needed to capture 50% of the total response (50% of the total SFC values in the data set -expressed as SFCs/10 6 PBMCs) was utilized as a performance metric.
As a first approach, we considered the "promiscuous binding capacity" of each peptide which is determined by the number of alleles bound (i.e., peptides binding with more alleles being better binders; and peptides with predicted IEDB consensus percentile rank ≤20 are called as "binding" to that allele). Using this approach, as shown in Figure 1a -b, an average of 30.91% (range 25.35%-40.08%) peptides were needed to capture 50% of the total response in the data set. In the second approach, we considered the "median consensus percentile rank" of each peptide, which is defined as the median of the IEDB consensus percentile ranks predicted for the set of 26 selected alleles. This approach was the most effective, with the top 26.26% (range 16.90%-38.38%) of the peptides capturing 50% of the total response (Figure 1a, c) . 
Exclusion of DP locus improves predictive efficacy
As different HLA class II loci appear to contribute differentially to human responses [6] , we hypothesized that examining the performance as a function of the class II locus may improve predictions. The average % of peptides required to capture 50% SFC for different combinations of DRB1, DRB3/4/5, DQ, and DP alleles are shown in Figure 2 . The best results (23.82%) were obtained when DP alleles were left out. The lower performance of methods incorporating DP molecules might be due to the fact that less binding data is available for these molecules leading to worse prediction algorithms. 
Optimal results obtained with a set of seven DRB1 and DRB3/4/5 alleles
We next examined the effect of varying the specific alleles included in the prediction panel. 
Predictions based on alleles frequent in specific donor cohorts
The HLA composition of a donor varies with their ethnicity. Accordingly, we examined the performance of the "median consensus percentile rank" predictions utilizing alleles present with frequencies of 10% or more in each specific donor population. As above, the best results (19.69%) were obtained using only DRB1 and DRB3/4/5 alleles (Figure 3 ). At the same time, the improvement seen here is minor suggesting that tailoring the prediction to a specific population has limited value.
Defining a universal prediction threshold
The percent of total peptides required to capture 50% of the response, as calculated here on a protein-by-protein basis is not available when considering individual peptides. To derive a standard prediction threshold, we calculated the median IEDB consensus percentile rank, using predictions for the seven DRB1 and DRB3/4/5 alleles highlighted above, associated with the selected set of peptides yielding 50% of the response. This value was found to be 19.82 (median consensus percentile rank from the seven selected alleles). 
Validation of the results with blind prediction using new data sets
The analyses above suggested that the optimal approach for efficient selection of epitope candidates would be based on determining the median consensus percentile rank across a selected panel of seven DR alleles (3 DRB1 alleles with frequency ≥12% in conjunction with 4 DRB3/4/5 alleles). To validate these results we examined overlapping peptides for two additional sets of proteins of immunological interest: 1) cockroach allergens and 2) pertussis vaccine antigens. When the range of approaches tried above was implemented against the two blind sets, the best performance was again achieved with the "median consensus percentile rank" approach. When the universal median IEDB consensus percentile threshold defined above (~20%) with the panel of seven DR alleles was utilized, the average % of SFC captured using peptides with median IEDB consensus percentile rank ≤ 20.0 was found to be 48.55%, confirming the validity of this prediction threshold.
CONCLUSIONS
We scrutinized the use of HLA class II binding predictions to identify sets of epitopes with high immunological activity. The results validate previous observations that promiscuous binders account for a high fraction of the total response. Compared to HLA class I predictions, the results are sobering, as this performance is remarkably less effective. This is in line with other recent studies [2] . At the same time, our results provide guidance for practical implementation of predictions, and identify specific subsets of HLA molecules that are most effectively considered by prediction schemes. The synthesis of approximately 20% of the peptides in a set of 15-mer peptides overlapping by 10 residues allows covering a 200-residue protein (otherwise covered by 40 overlapping peptides) with 10 peptides, which still constitutes significant cost savings.
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